sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Respiratory Disease Testing Market (Imaging, Spirometry, Peak Flow, Blood Gas, Lung Volume, and other Tests) for Hospitals, Physician Offices and Clinical Laboratories: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

Respiratory Disease Testing Market (Imaging, Spirometry, Peak Flow, Blood Gas,...

Home / Categories / Healthcare
Respiratory Disease Testing Market (Imaging, Spirometry, Peak Flow, Blood Gas, Lung Volume, and other Tests) for Hospitals, Physician Offices and Clinical Laboratories: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021
Respiratory Disease Testing Market (Imaging,...
Report Code
RO1/106/1058

Publish Date
29/Aug/2016

Pages
110
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

Chapter 1. Introduction


1.1. Report description and scope

1.2. Research scope

1.3. Research methodology


1.3.1. Market research process

1.3.2. Market research methodology

Chapter 2. Executive Summary


2.1. Global Respiratory Disease Testing market, 2015 - 2021 (USD Billion)

2.2. Global Respiratory Disease Testing market: Snapshot

Chapter 3. Respiratory Disease Testing  Market Dynamics


3.1. Introduction

3.2. Value chain analysis

3.3. Market drivers


3.3.1. Increase in Prevalence of Respiratory Diseases

3.3.2. Changing Lifestyle and Improvement in Medical Facilities

3.4. Market restraints


3.4.1. Low adoption rate of advanced spirometers and digital radiography systems

3.5. Opportunities


3.5.1. Huge Potential Presented by Emerging Markets in Asia-Pacific

3.6. Porters five forces analysis


3.6.1. Bargaining power of suppliers 3.6.2. Bargaining power of buyers

3.6.3. Threat from new entrants

3.6.4. Threat from new substitutes

3.6.5. Degree of competition

3.7. Market attractiveness analysis


3.7.1. Market attractiveness analysis, by product segment

3.7.2. Market attractiveness analysis, by end-user segment

3.7.3. Market attractiveness analysis, by regional segment

Chapter 4. Global Respiratory Disease Testing Market  Competitive Landscape


4.1. Company market share, 2015 (Subject to data availability)

4.2. Price trend analysis

Chapter 5. Global Respiratory Disease Testing Market  Product Segment Analysis


5.1. Global Respiratory Disease Testing market: Product segment overview


5.1.1. Global Respiratory Disease Testing market revenue share, by product segment, 2015 and 2021

5.2. Lung Volume


5.2.1. Global Lung Volume market , 2015  2021 (USD Billion)

5.3. Imaging


5.3.1. Global Imaging market, 2015  2021 (USD Billion)

5.4. Spirometry


5.4.1. Global Spirometry market, 2015  2021 (USD Billion)

5.5. Peak Flow


5.5.1. Global Peak Flow market, 2015  2021 (USD Billion)

5.6. Blood Gas


5.6.1. Global Blood Gas market, 2015  2021 (USD Billion)

5.7. Others


5.7.1. Global Other Tests market, 2015  2021 (USD Billion)

Chapter 6. Global Respiratory Disease Testing Market  End-user Segment Analysis


6.1. Global Respiratory Disease Testing market: End-user segment overview


6.1.1. Global Respiratory Disease Testing market revenue share, by End-user segment, 2015 and 2021

6.2. Hospitals


6.2.1. Global Hospitals market , 2015  2021 (USD Billion)

6.3. Physician Offices


6.3.1. Global Physician Offices market, 2015  2021 (USD Billion)

6.4. Clinical Laboratories


6.4.1. Global Clinical Laboratories market, 2015  2021 (USD Billion)

Chapter 7. Global Respiratory Disease Testing Market  Regional Segment Analysis


7.1. Global Respiratory Disease Testing Market: Regional Overview


7.1.1. Global Respiratory Disease Testing Market Volume Share By Region, 2015 And 2021

7.2. North America


7.2.1. North America Respiratory Disease Testing Market Revenue, By Product, 2015  2021, (USD Billion)

7.2.2. North America Respiratory Disease Testing Market Revenue, By End-User, 2015  2021, (USD Billion)

7.2.3. U.S.


7.2.3.1. U.S. Respiratory Disease Testing Market Revenue, By Product, 2015  2021, (USD Billion)

7.2.3.2. U.S. Respiratory Disease Testing Market Revenue, By End-User, 2015  2021 (USD Billion)

7.3. Europe


7.3.1. Europe Respiratory Disease Testing Market Revenue, By Product, 2015  2021, (USD Billion)

7.3.2. Europe Respiratory Disease Testing Market Revenue, By End-User, 2015  2021 (USD Billion)

7.3.3. UK


7.3.3.1. UK Respiratory Disease Testing Market Revenue, By Product, 2015  2021, (USD Billion)

7.3.3.2. UK Respiratory Disease Testing Market Revenue, By End-User, 2015  2021 (USD Billion)

7.3.4. France


7.3.4.1. France Respiratory Disease Testing Market Revenue, By Product, 2015  2021, (USD Billion)

7.3.4.2. France Respiratory Disease Testing Market Revenue, By End-User, 2015  2021, (USD Billion)

7.3.5. Germany


7.3.5.1. Germany Respiratory Disease Testing Market Revenue, By Product, 2015  2021, (USD Billion)

7.3.5.2. Germany Respiratory Disease Testing Market Revenue, By End-User, 2015  2021, (USD Billion)

7.4. Asia Pacific


7.4.1. Asia Pacific Respiratory Disease Testing Market Revenue, By Product, 2015  2021, (USD Billion)

7.4.2. Asia Pacific Respiratory Disease Testing Market Revenue, By End-User, 2015  2021 (USD Billion)

7.4.3. China


7.4.3.1. China Respiratory Disease Testing Market Revenue, By Product, 2015  2021, (USD Billion)

7.4.3.2. China Respiratory Disease Testing Market Revenue, By End-User, 2015  2021 (USD Billion)

7.4.4. Japan


7.4.4.1. Japan Respiratory Disease Testing Market Revenue, By Product, 2015  2021, (USD Billion)

7.4.4.2. Japan Respiratory Disease Testing Market Revenue, By End-User, 2015  2021 (USD Billion)

7.4.5. India


7.4.5.1. India Respiratory Disease Testing Market Revenue, By Product, 2015  2021, (USD Billion)

7.4.5.2. India Respiratory Disease Testing Market Revenue, By End-User, 2015  2021 (USD Billion)

7.5. Latin America


7.5.1. Latin America Respiratory Disease Testing Market Revenue, By Product, 2015  2021, (USD Billion)

7.5.2. Latin America Respiratory Disease Testing Market Revenue, By End-User, 2015  2021 (USD Billion)

7.5.3. Brazil


7.5.3.1. Brazil Respiratory Disease Testing Market Revenue, By Product, 2015  2021, (USD Billion)

7.5.3.2. Brazil Respiratory Disease Testing Market Revenue, By End-User, 2015  2021 (USD Billion)

7.6. Middle East And Africa


7.6.1. Middle East And Africa Respiratory Disease Testing Market Revenue, By Product, 2015  2021, (USD Billion)

7.6.2. Middle East And Africa Respiratory Disease Testing Market Revenue, By End-User, 2015  2021 (USD Billion)

Chapter 8. Company Profile


8.1. ndd Medical Technologies, Inc.


8.1.1. Overview

8.1.2. Financials

8.1.3. Product Portfolio

8.1.4. Business Strategy

8.1.5. Recent Developments

8.2. Carestream Health, Inc.


8.2.1. Overview

8.2.2. Financials

8.2.3. Product Portfolio

8.2.4. Business Strategy

8.2.5. Recent Developments

8.3. SDI Diagnostics


8.3.1. Overview

8.3.2. Financials

8.3.3. Product Portfolio

8.3.4. Business Strategy

8.3.5. Recent Developments

8.4. Nihon Kohden Corporation


8.4.1. Overview

8.4.2. Financials

8.4.3. Product Portfolio

8.4.4. Business Strategy

8.4.5. Recent Developments

8.5. CareFusion Corporation


8.5.1. Overview

8.5.2. Financials

8.5.3. Product Portfolio

8.5.4. Business Strategy

8.5.5. Recent Developments

8.6. Smiths Medical


8.6.1. Overview

8.6.2. Financials

8.6.3. Product Portfolio

8.6.4. Business Strategy

8.6.5. Recent Developments

8.7. COSMED


8.7.1. Overview

8.7.2. Financials

8.7.3. Product Portfolio

8.7.4. Business Strategy

8.7.5. Recent Developments

8.8. Perkin Elmer, Inc.


8.8.1. Overview

8.8.2. Financials

8.8.3. Product Portfolio

8.8.4. Business Strategy

8.8.5. Recent Developments

8.9. Philips Healthcare


8.9.1. Overview

8.9.2. Financials

8.9.3. Product Portfolio

8.9.4. Business Strategy

8.9.5. Recent Developments

8.10. MGC Diagnostic Corporation


8.10.1. Overview

8.10.2. Financials

8.10.3. Product Portfolio

8.10.4. Business Strategy

8.10.5. Recent Developments

8.11. Futuremed America, Inc.


8.11.1. Overview

8.11.2. Financials

8.11.3. Product Portfolio

8.11.4. Business Strategy

8.11.5. Recent Developments

8.12. GE Healthcare


8.12.1. Overview

8.12.2. Financials

8.12.3. Product Portfolio

8.12.4. Business Strategy

8.12.5. Recent Developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com